Canada finalises guidance on applications for implantable cardiac leads
This article was originally published in SRA
Executive Summary
Health Canada has issued final guidance on different types of submissions relating to implantable cardiac leads1. The guideline, which comes into effect on 25 October, aims to help manufacturers of implantable cardiac leads prepare applications for a medical device licence, a licence amendment or investigational testing.